Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis.
暂无分享,去创建一个
Lei Xu | Dai Fukumura | Ricky T. Tong | Raju Kucherlapati | Rakesh K Jain | R. Kucherlapati | R. Jain | D. Fukumura | T. Padera | Lei Xu | Timothy P Padera | Jeroen Hagendoorn | Ricky Tong | Qingcong Lin | Jennifer Lobo | J. Hagendoorn | Qingcong Lin | Jennifer Lobo
[1] D. Hanahan,et al. MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.
[2] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.
[3] Ricky T. Tong,et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.
[4] D. Hanahan,et al. Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis. , 1998, The International journal of developmental biology.
[5] Rakesh K Jain,et al. Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.
[6] T. Blankenstein. The role of tumor stroma in the interaction between tumor and immune system. , 2005, Current opinion in immunology.
[7] R. Jain,et al. Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. , 1993, Microvascular research.
[8] R. Jain,et al. Intratumoral lymphatic vessels: a case of mistaken identity or malfunction? , 2002, Journal of the National Cancer Institute.
[9] Jeffrey W. Clark,et al. Lessons from phase III clinical trials on anti-VEGF therapy for cancer , 2006, Nature Clinical Practice Oncology.
[10] R K Jain,et al. Interstitial hypertension in superficial metastatic melanomas in humans. , 1991, Cancer research.
[11] Rakesh K. Jain,et al. Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors , 2004, Cancer Research.
[12] Rakesh K. Jain,et al. Pathology: Cancer cells compress intratumour vessels , 2004, Nature.
[13] D. Hanahan,et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.
[14] G. Christofori,et al. Recent advances in cancer research: mouse models of tumorigenesis. , 2002, Biochimica et biophysica acta.
[15] R. Kucherlapati,et al. Increased susceptibility to UV-induced skin carcinogenesis in polymerase eta-deficient mice. , 2006, Cancer research.
[16] R. Jain. The next frontier of molecular medicine: Delivery of therapeutics , 1998, Nature Medicine.
[17] Rakesh K Jain,et al. Molecular regulation of vessel maturation , 2003, Nature Medicine.
[18] R K Jain,et al. Tumor angiogenesis and interstitial hypertension. , 1996, Cancer research.
[19] R. Jain. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.
[20] Dai Fukumura,et al. Peritumor Lymphatics Induced by Vascular Endothelial Growth Factor-C Exhibit Abnormal Function , 2004, Cancer Research.
[21] P. Gullino,et al. Angiogenesis and oncogenesis. , 1978, Journal of the National Cancer Institute.
[22] T. Jacks,et al. Cancer Modeling in the Modern Era Progress and Challenges , 2002, Cell.